Cleaning Validation
Cleaning validation is documented evidence that a cleaning procedure consistently reduces product residues, cleaning agents, and bioburden on shared equipment to scientifically justified, health-based limits. It is the control that stops one product cross-contaminating the next — and the modern expectation is that its limits are derived from toxicology, not convention.
What an explainer is not
A topic explainer is SPEQ’s synthesis of what a practice involves, cited to the standards that govern it. It does not reproduce their text, and it does not determine which of them apply to your product or process.
[ POSITION IN THE FRAMEWORK ]
7 DIMENSIONS · 21 LINKSCleaning validation is a GMP control with one sharp purpose — stopping carry-over between products on shared equipment — so it lands hardest on the multi-product sectors below and is evidenced in the lab and batch systems.
06 · QUALITY MATURITY — CLEANING VALIDATION, REACTIVE TO ADAPTIVE
"Visually clean" and habit set the standard; worst-case locations and hold times are undocumented.
Protocols and acceptance limits exist, but limits rest on legacy conventions like 10 ppm rather than toxicology.
Limits derive from HBEL/PDE via MACO; swab recovery is validated and worst-case grouping is justified in writing.
Ongoing verification trends cleaning data; changes to products, equipment, or agents trigger risk-based revalidation.
Cleaning risk shapes product-introduction and equipment-design decisions before validation is ever needed.
SPEQ’s shared five-stage progression, labelled synthesis — not the FDA QMM rating scale. Where does your organization sit? Score your quality system →
07 · REGULATORY & EVIDENCE
GOVERNING STANDARDS · 3
Derived from the 3 standards SPEQ maps to this subject, across 3 regulatory bodies: FDA, EMA, ICH.
RECORDS & OBJECTIVE EVIDENCE
- Toxicologist-derived HBEL/PDE assessments for each compound
- MACO calculations behind every acceptance limit
- Swab and rinse recovery studies for the analytical methods
- A documented worst-case (bracketing) grouping rationale
- Cleaning validation protocols, reports, and ongoing verification data
COMMON INSPECTION FINDINGS
- Acceptance limits not health-based and not otherwise justified
- Swab sampling relied on without a validated recovery factor
- Worst-case product and location selection undocumented
- New products introduced with no reassessment of cleaning validation
- Dirty- and clean-hold times asserted but never validated
Why it matters — cross-contamination
Wherever equipment is shared between products, residue from one batch can carry into the next. Cleaning validation is how a manufacturer proves that carry-over is controlled to a safe level. It is a direct patient-safety control, and inadequate cleaning validation is a recurring GMP inspection finding — especially in multi-product facilities.
From arbitrary limits to health-based limits (HBEL/PDE)
Legacy limits — 10 ppm in the next product, or a thousandth of the therapeutic dose, or "visually clean" — were pragmatic but not scientific. The regulatory direction of travel, led by EMA guidance and ICH Q9-style risk thinking, is to Health-Based Exposure Limits: a Permitted Daily Exposure (PDE) or Acceptable Daily Exposure (ADE) derived by a toxicologist from the actual pharmacology and toxicology of the compound.
From the HBEL you calculate a Maximum Allowable Carryover (MACO) — the most residue that may carry into the next product without exceeding the safe daily exposure — and that becomes the acceptance limit the validation must meet.
Sampling and analytical methods
Two sampling approaches dominate: swab sampling (a defined area of the worst-case, hardest-to-clean location, with a validated recovery factor) and rinse sampling (the final rinse analysed for residue). Analytical methods range from specific (HPLC for a defined analyte) to non-specific (Total Organic Carbon). Recovery studies are essential — an unvalidated swab recovery can make a dirty surface look clean.
Lifecycle, worst-case grouping, and revalidation
Validating every product on every piece of equipment is impractical, so cleaning validation uses worst-case (bracketing) grouping: validate the hardest-to-clean, most-toxic, least-soluble representative, and cover the group by justification. EU GMP Annex 15 frames cleaning validation within the wider qualification and validation lifecycle, with revalidation triggered by changes to products, equipment, or the cleaning procedure. Ongoing verification (including visual inspection) confirms the validated state holds.
WORKED EXAMPLE — SPEQ SYNTHESIS
A hypothetical multi-product oral solid dose facility introduces a new high-potency compound onto an existing manufacturing train. The train currently makes four products with an established cleaning process. The question is what cleaning validation is now required, and against what limit.
Re-open the grouping before re-running anything
The existing worst case was chosen against the four products that were there. A new compound can displace it — on solubility, on potency, or on cleanability — and validating the old worst case against new criteria proves the wrong thing. Grouping is the first thing the new product changes.
Derive the limit from health-based exposure, and show the arithmetic
The permitted residue follows from the toxicological evaluation, the shared surface area of the train and the smallest following batch. Each of those three is a real number from a real source, and a limit presented without them cannot be reviewed or reproduced.
Check that the analytical method can actually see the limit
A limit below the method detection limit is not a limit. This is the step that most often sends the exercise back to the laboratory, and finding it after protocol approval rather than before is an avoidable cost.
Choose swab locations on hardest-to-clean rationale, and run the recovery study first
Sampling points are selected because they are difficult, not because they are reachable. A swab result without an established recovery factor is not a residue measurement, and the recovery study has to precede execution rather than accompany it.
Set acceptance criteria per residue type and justify the run count
Product residue, cleaning agent and microbial limits are three separate criteria. Three runs is a convention, not a requirement; the number should follow from the variability the process shows and the confidence the risk demands.
Define what happens after validation before you execute it
Routine monitoring, the trigger for revalidation, and the response to a result approaching the limit. A validated cleaning process with no monitoring strategy degrades invisibly until something else finds it.
A protocol whose worst case has been re-determined against the new product, whose limit is derived and shown, whose method is demonstrably capable of measuring it, and whose post-validation monitoring is defined. Whether the cleaning process is acceptable is decided by executing it and by the quality unit reading the result — not by the protocol.
WHAT WOULD CHANGE THIS
- If the new compound is genuinely incompatible with shared equipment on a toxicological basis, the answer is dedicated equipment or a dedicated train, and no cleaning validation makes that decision go away.
- If the health-based exposure limit has not been established by a qualified toxicologist, step two cannot proceed on an assumed value — the limit is an input, not an output of this exercise.
- A single-product facility faces a different question entirely: carryover between batches of the same product, where the limit derivation above does not apply.
FREQUENTLY ASKED
What is cleaning validation?
Documented evidence that a cleaning procedure consistently reduces product residues, cleaning agents, and bioburden on shared equipment to scientifically justified, health-based limits — preventing cross-contamination between products.
What is an HBEL or PDE?
A Health-Based Exposure Limit (HBEL), often expressed as a Permitted Daily Exposure (PDE) or Acceptable Daily Exposure (ADE), is a toxicologically-derived safe daily exposure to a compound. Modern cleaning limits are derived from the HBEL rather than from legacy rules like 10 ppm or 1/1000th of a dose.
What is MACO?
Maximum Allowable Carryover — the greatest amount of residue that may carry into the next product without exceeding the health-based safe exposure. It is calculated from the HBEL/PDE and becomes the cleaning-validation acceptance limit.
Swab or rinse sampling?
Both are used. Swab sampling targets the worst-case, hardest-to-clean locations with a validated recovery factor; rinse sampling analyses the final rinse for residue over a larger area. They are complementary, and recovery studies are essential for either to be meaningful.